Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

US hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker struggles with its post-pandemic financial ...

Elon Musk appeared onstage at a rally for the former president this weekend, but Silicon Valley was abuzz about Ben ...

Department of Justice is arguing that any company working for government can seize whatever patents it wants. That goes ...

What are you looking forward to this fall and winter? Getting together with friends to cheer for your favorite teams?

The FDA has approved a new COVID-19 vaccine, but experts debate the best time to get it.

According to Research by , Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for Immunization, with Key Contributions from mRNA and ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Protesters worldwide demand end to Israel’s year of war on Gaza Protesters have marched this weekend in cities around the world to demand an end to Israel’s brutal war on Gaza.

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory ... stage pipeline from Bavarian Nordic and Moderna. Johnson & Johnson was also developing ...

The terrorists took the lives of some Israelis with special needs, and these losses, along with the trauma and dislocations of the war, have caused great suffering in this community. Sen. Lindsey ...